Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

FDA Approves Abrocitinib for Moderate to Severe Atopic Dermatitis in Adult Patients – HCPLive,

The decision was supported by 5 clinical trials that resulted in significant improvements in skin clearance, extent of disease, and severity., The decision was supported by 5 clinical trials that resulted in significant improvements in skin clearance, extent of disease, and severity., Read More

Scroll to Top